AstraZeneca Pharmaceuticals LP

Form 483 issued July 22, 2022 · Philadelphia, Pennsylvania

Inspection
Jul 11 – Jul 22, 2022
Investigator
Unnee Ranjan
Observations
3
Pages
4
FEI number
3004829714

In short: On July 22, 2022, FDA issued a Form 483 with 3 observations to AstraZeneca Pharmaceuticals LP in Philadelphia, Pennsylvania (FEI 3004829714) after an inspection that ran Jul 11 – Jul 22, 2022. The investigator was Unnee Ranjan. Most observations concern production and facilities & equipment.

At a glance

Production and facilities & equipment account for 2 of 3 observations.

Production1
Facilities & equipment1
Quality system1

What FDA observed

Preview: the opening words of each observation
  1. 01

    Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not…

  2. 02

    Equipment used in the manufacture, processing, packing or holding of drug products is not of appropriate…

  3. 03

    Investigations of an unexplained discrepancy did not extend to other batches of…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at AstraZeneca Pharmaceuticals LP?

FDA listed 3 observations on this Form 483, mostly about production, facilities & equipment and quality system. The opening words of each observation are shown on this page.

Who inspected AstraZeneca Pharmaceuticals LP?

Unnee Ranjan is named on this Form 483, for the inspection of Jul 11 – Jul 22, 2022. Each investigator has a profile showing what they cite most.

When was AstraZeneca Pharmaceuticals LP inspected by FDA?

The inspection ran Jul 11 – Jul 22, 2022, and the Form 483 is dated July 22, 2022.

How do I get the full Form 483 for AstraZeneca Pharmaceuticals LP?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free